64859-35-4 Usage
Description
(3-TERT-BUTOXY-PHENYL)-METHANOL, also known as 3-tert-butoxybenzyl alcohol, is a chemical compound with the molecular formula C11H16O2. It is a white crystalline solid at room temperature and possesses a molecular weight of 180.24 g/mol and a melting point of 96-97°C. This versatile intermediate is widely used in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals due to its reactivity and ability to undergo a wide array of chemical reactions.
Uses
Used in Pharmaceutical Industry:
(3-TERT-BUTOXY-PHENYL)-METHANOL is used as a versatile intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving the efficacy of existing ones.
Used in Agrochemical Industry:
(3-TERT-BUTOXY-PHENYL)-METHANOL is used as a building block in the production of agrochemicals, helping to create effective solutions for pest control and crop protection.
Used in Fine Chemicals Industry:
(3-TERT-BUTOXY-PHENYL)-METHANOL is used as a key component in the synthesis of various fine chemicals, enabling the creation of high-quality specialty products for diverse applications.
Safety Precautions:
It is important to handle (3-TERT-BUTOXY-PHENYL)-METHANOL with care and follow proper safety protocols due to its potential hazards, ensuring the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 64859-35-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,8,5 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 64859-35:
(7*6)+(6*4)+(5*8)+(4*5)+(3*9)+(2*3)+(1*5)=164
164 % 10 = 4
So 64859-35-4 is a valid CAS Registry Number.
64859-35-4Relevant articles and documents
Inhibitors of prenyl-protein transferase
-
, (2008/06/13)
The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
